Duration:12 months Quantity: aflibercept 2.0mg/0.05mL Bimonthly injection

2 trials

Sponsors

Department of Ophthalmology, Shiga University of Medical Science, Department of Ophthalmology, Shiga University of Medical Science

Conditions

branch retinal vein occlusioncentral retinal vein occlusion

Unknown Phase

Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for central retinal vein occlusion

Active, not recruitingJPRN-UMIN000013405

Department of Ophthalmology, Shiga University of Medical Sciencecentral retinal vein occlusion

Start: 2014-03-13Target: 50Updated: 2026-06-29

Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for branch retinal vein occlusion

Active, not recruitingJPRN-UMIN000018999

Department of Ophthalmology, Shiga University of Medical Sciencebranch retinal vein occlusion

Start: 2015-09-25Target: 40Updated: 2026-06-29